Microencapsulation of probiotics using gras-compatible polymers
University of Minnesota researchers propose using GRAS-compatible polymers like pectin and carrageenan to encapsulate probiotics, protecting them in low pH environments. This technology aims to enhance the stability and controlled release of probiotics in neutral pH conditions.
Overview
The proposed solution focuses on the microencapsulation of probiotics using Generally Recognized as Safe (GRAS) compatible polymers. This innovative approach aims to protect probiotics from the harsh acidic conditions of the stomach, ensuring their release and activity in the more neutral pH environment of the intestines. By employing polymers such as pectin, carrageenan, xanthan gum, and dextran, the encapsulated probiotics are not only shielded from low pH environments but also maintain their viability and efficacy.
Technical specifications
The technology employs biocompatible polymers to create a protective coating around probiotic cells. These polymers, including pectin, carrageenan, and others, are known for their safety and effectiveness in pharmaceutical applications:
- Pectin and Carrageenan: Natural polymers that form gels in acidic conditions, dissolving at neutral pH to release probiotics.
- Xanthan Gum and Dextran: Provide structural stability and enhance the encapsulation efficiency.
- Ethylcellulose: Offers additional protection due to its hydrophobic properties, ensuring the probiotics remain intact until reaching targeted sites.
The encapsulation process builds on existing techniques used for active pharmaceutical ingredients, adapting them to optimize probiotic stability and release.
Technology readiness level
Currently at Technology Readiness Level 3, this technology is in the experimental phase, with initial validation focused on determining the most effective polymer systems for encapsulating probiotics. The next steps involve testing the viability and stability of these systems under simulated gastrointestinal conditions, aiming to identify the best formulation and process within a year.
About University of Minnesota
The University of Minnesota is a flagship, comprehensive public research university spanning multiple campuses, with a large research enterprise and clinical integration. Industry engages through co-located labs on the Twin Cities campuses, access to an academic health system for clinical translation, and pilot and field-testing facilities that speed scale-up. A statewide extension network and outreach centers provide real-world sites and data partnerships across Minnesota, while proximity to a dense medtech and Fortune 500 corridor enables frequent collaboration. Research is supported by competitive federal funding, including NIH, NSF, DOE, USDA, and DoD. A dedicated technology transfer office manages IP, licensing, sponsored research agreements, and startup incubation to speed commercialization.
delivered to your inbox.